Literature DB >> 7675641

[18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].

U Feine1, R Lietzenmayer, J P Hanke, H Wöhrle, W Müller-Schauenburg.   

Abstract

In 27 examinations of 24 patients with differentiated thyroid carcinoma an alternating pattern of metastases with either 131I- or FDG-uptake was found. In the follow-up of these patients this flip-flop pattern was seen in 89% (17/19) of patients with metastases and uptake of 131I or FDG as described here as uptake types 1 and 2 (type 1: FDG-positive and 131I-negative; type 2: FDG-negative and 131I-positive). In 4 patients a mixed type was observed (uptake type 3), i.e. a combination of metastases with uptake types 1 and 2 in the same patient. Metastases of papillary or follicular thyroid carcinoma without uptake of iodine have all been found to be FDG-positive in patients with an increase of thyroglobulin and with negative diagnostic results from other imaging modalities, and were histologically confirmed by surgery. False-negative or false-positive cases were not observed in this study. The FDG uptake showed an inverse proportionality to iodine uptake and to tumor differentiation. Increased glucose metabolism is a sign of higher malignancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675641

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  26 in total

Review 1.  An update on diagnostic methods in the investigation of diseases of the thyroid.

Authors:  M J Reinhardt; E Moser
Journal:  Eur J Nucl Med       Date:  1996-05

2.  Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer.

Authors:  Domenico Albano; Maria Beatrice Panarotto; Rexhep Durmo; Carlo Rodella; Francesco Bertagna; Raffaele Giubbini
Journal:  Endocrine       Date:  2018-08-15       Impact factor: 3.633

Review 3.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

Review 4.  The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview.

Authors:  Giorgio Treglia; Barbara Muoio; Luca Giovanella; Massimo Salvatori
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-02       Impact factor: 2.503

Review 5.  Role of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients affected by differentiated thyroid carcinoma, high thyroglobulin level, and negative ¹³¹I scan: review of the literature.

Authors:  Francesco Bertagna; Giorgio Biasiotto; Emanuela Orlando; Giovanni Bosio; Raffaele Giubbini
Journal:  Jpn J Radiol       Date:  2010-11-27       Impact factor: 2.374

6.  ¹⁸F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy.

Authors:  Sandra J Rosenbaum-Krumme; Rainer Görges; Andreas Bockisch; Ina Binse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-21       Impact factor: 9.236

7.  Influence of TSH on uptake of [18F]fluorodeoxyglucose in human thyroid cells in vitro.

Authors:  J T Deichen; C Schmidt; O Prante; S Maschauer; T Papadopoulos; T Kuwert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

8.  The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.

Authors:  Martin Barrio; Johannes Czernin; Michael W Yeh; Miguel F Palma Diaz; Pawan Gupta; Martin Allen-Auerbach; Christiaan Schiepers; Ken Herrmann
Journal:  Nucl Med Commun       Date:  2016-12       Impact factor: 1.690

9.  Positron emission tomography for detecting iodine-131 nonvisualized metastasis of well-differentiated thyroid carcinoma: two case reports.

Authors:  T S Huang; P U Chieng; C C Chang; R F Yen
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

10.  Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer.

Authors:  F Grünwald; A Schomburg; H Bender; E Klemm; C Menzel; T Bultmann; H Palmedo; J Ruhlmann; B Kozak; H J Biersack
Journal:  Eur J Nucl Med       Date:  1996-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.